ZA200701533B - Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether - Google Patents

Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether

Info

Publication number
ZA200701533B
ZA200701533B ZA200701533A ZA200701533A ZA200701533B ZA 200701533 B ZA200701533 B ZA 200701533B ZA 200701533 A ZA200701533 A ZA 200701533A ZA 200701533 A ZA200701533 A ZA 200701533A ZA 200701533 B ZA200701533 B ZA 200701533B
Authority
ZA
South Africa
Prior art keywords
esters
salts
butyl ether
methyl tert
abirater
Prior art date
Application number
ZA200701533A
Other languages
English (en)
Inventor
Hunt Neil John
Original Assignee
Btg Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Btg Int Ltd filed Critical Btg Int Ltd
Publication of ZA200701533B publication Critical patent/ZA200701533B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
ZA200701533A 2004-08-24 2005-08-23 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether ZA200701533B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0418900.7A GB0418900D0 (en) 2004-08-24 2004-08-24 Novel salt forms

Publications (1)

Publication Number Publication Date
ZA200701533B true ZA200701533B (en) 2008-08-27

Family

ID=33104570

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200701533A ZA200701533B (en) 2004-08-24 2005-08-23 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether

Country Status (22)

Country Link
US (5) US7700766B2 (zh)
EP (1) EP1789432B1 (zh)
JP (1) JP5069561B2 (zh)
KR (2) KR101358661B1 (zh)
CN (2) CN102863498B (zh)
AT (1) ATE472553T1 (zh)
AU (1) AU2005276298C1 (zh)
BR (1) BRPI0514543A (zh)
CA (1) CA2576922C (zh)
CY (1) CY1110800T1 (zh)
DE (1) DE602005022083D1 (zh)
DK (1) DK1789432T3 (zh)
ES (1) ES2345345T3 (zh)
GB (1) GB0418900D0 (zh)
HK (2) HK1103091A1 (zh)
MX (1) MX2007002032A (zh)
NZ (1) NZ553085A (zh)
PL (1) PL1789432T3 (zh)
PT (1) PT1789432E (zh)
SI (1) SI1789432T1 (zh)
WO (1) WO2006021776A1 (zh)
ZA (1) ZA200701533B (zh)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569275B2 (en) 2002-08-28 2013-10-29 Harbor Therapeutics, Inc. Steroids having 7-oxgen and 17-heteroaryl substitution
GB0418900D0 (en) * 2004-08-24 2004-09-29 Btg Int Ltd Novel salt forms
PL1781683T3 (pl) * 2004-08-24 2012-04-30 Btg Int Ltd Sposób wytwarzania 17-winylo-trifluorometanosulfonianów jako związków pośrednich
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
PL2478907T3 (pl) * 2006-08-25 2021-10-25 Janssen Oncology, Inc. Kompozycje do leczenia nowotworu
GEP20156250B (en) 2009-06-26 2015-02-25 Novartis Ag 1,3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17
EP2627648A1 (en) 2010-09-16 2013-08-21 Novartis AG 17aHYDROXYLASE/C17,20-LYASE INHIBITORS
CN102558274B (zh) * 2010-12-08 2014-10-15 深圳万乐药业有限公司 一种适合工业化生产醋酸阿比特龙的合成方法
CN102030798B (zh) * 2010-12-17 2012-10-17 深圳万乐药业有限公司 一种醋酸阿比特龙的纯化方法
ES2656218T3 (es) 2011-04-28 2018-02-26 Novartis Ag Inhibidores de 17 alfa-hidroxilasa/C17,20-liasa
ES2590753T3 (es) 2011-10-10 2016-11-23 Zach System Proceso para la preparación de esteroides 17-sustituidos
EP2607371A1 (en) 2011-12-23 2013-06-26 Crystal Pharma, S.A.U. Processes for the preparation of abiraterone and related compouds
CN103172690B (zh) * 2011-12-23 2016-08-24 重庆医药工业研究院有限责任公司 醋酸阿比特龙及其中间体的制备方法
CN105461777B (zh) * 2012-01-04 2017-07-18 连云港润众制药有限公司 一种醋酸阿比特龙的纯化方法
CN103254265B (zh) 2012-02-21 2016-07-13 上海希迈医药科技有限公司 醋酸阿比特龙三氟乙酸盐及其制备方法和应用
CN103360458B (zh) * 2012-03-26 2015-05-20 信泰制药（苏州）有限公司 一种阿比特龙的合成方法
CN102731605B (zh) * 2012-06-19 2016-04-13 鲁南制药集团股份有限公司 一种醋酸阿比特龙的纯化方法
CN103665084A (zh) * 2012-09-04 2014-03-26 重庆安格龙翔医药科技有限公司 一种制备醋酸阿比特龙的方法
CN102816200B (zh) * 2012-09-05 2015-04-15 中山大学 一种醋酸阿比特龙的制备方法
CN102816201A (zh) * 2012-09-25 2012-12-12 成都伊诺达博医药科技有限公司 一种阿比特龙的纯化方法
WO2014058785A1 (en) 2012-10-10 2014-04-17 Novartis Ag Combination therapy
ITMI20121788A1 (it) 2012-10-22 2014-04-23 Olon Spa Procedimento per la purificazione di abiraterone acetato
WO2014071983A1 (en) 2012-11-09 2014-05-15 Synthon Bv Process for making the 17-triflate intermediate of abiraterone-3-acetate
CA2890589A1 (en) 2012-11-09 2014-05-15 Synthon Bv Process for making abiraterone-3-acetate
TWI570131B (zh) * 2012-11-13 2017-02-11 賽克系統公司 製備１７－經取代類固醇之方法
WO2014075978A1 (en) 2012-11-16 2014-05-22 Synthon B.V. Process for the production of abiraterone-3-acetate involving an enol trliflation reaction in the presence of an alkoxy-pyridine compound
CN103059091B (zh) * 2012-11-22 2017-04-19 常州靶点医药科技有限公司 一种避免重金属残留的醋酸阿比特龙的制备方法
US9962452B2 (en) 2013-02-04 2018-05-08 Zhuhai Beihai Biotech Co., Ltd. Soluble complexes of drug analogs and albumin
EP2792682B1 (en) 2013-04-19 2016-11-09 Zach System Process for producing a solid form of abiraterone acetate
CN103242410B (zh) * 2013-05-09 2015-08-26 苏州明锐医药科技有限公司 醋酸阿比特龙的制备方法
WO2014207762A1 (en) * 2013-06-24 2014-12-31 Sun Pharmaceutical Industries Ltd. Process for preparation of abiraterone acetate
ES2705579T3 (es) 2013-06-28 2019-03-26 Scinopharm Taiwan Ltd Procedimiento de preparación de abiraterona e intermedios de la misma
CZ306623B6 (cs) 2013-07-04 2017-04-05 Zentiva, K.S. Soli abirateronu acetátu
EP3080141A1 (en) 2013-12-12 2016-10-19 Basf Se Solid form of abiraterone acetate
US9556219B2 (en) 2014-01-28 2017-01-31 Olon S.P.A. Procedure for the preparation of abiraterone acetate and intermediates thereof
CN103965282B (zh) * 2014-04-21 2016-01-20 武汉百科药物开发有限公司 一种醋酸阿比特龙的制备方法
US9315541B2 (en) * 2014-05-20 2016-04-19 Olon S.P.A. Process for the preparation of unsaturated trifluoromethanesulfonate steroid derivatives
CN105294806A (zh) * 2014-06-13 2016-02-03 江苏希迪制药有限公司 一种制备醋酸阿比特龙中间体的方法
US9937259B2 (en) 2014-06-27 2018-04-10 Zhuhai Beihai Biotech Co., Ltd. Abiraterone derivatives and non-covalent complexes with albumin
US10201617B2 (en) 2014-10-24 2019-02-12 Zhuhai Beihai Biotech Co., Ltd. 3-substituted piperidine-2, 6-diones and non-covalent complexes with albumin
CN104447934B (zh) * 2014-12-08 2017-03-15 深圳科兴生物工程有限公司 一种醋酸阿比特龙的纯化方法
US10722527B2 (en) 2015-04-10 2020-07-28 Capsugel Belgium Nv Abiraterone acetate lipid formulations
CA3031705A1 (en) 2016-07-29 2018-02-01 Janssen Pharmaceutica Nv Treatment of prostate cancer with niraparib
WO2018071544A1 (en) 2016-10-11 2018-04-19 Zhuhai Beihai Biotech Co., Ltd. Abiraterone derivative and formulations thereof
CN108586561B (zh) * 2018-04-03 2020-08-04 科兴生物制药股份有限公司 一种制备醋酸阿比特龙的方法
CN114026106A (zh) 2019-03-06 2022-02-08 普洛拉治疗公司 阿比特龙前药
CN112812147A (zh) * 2019-11-15 2021-05-18 江苏佳尔科药业集团股份有限公司 一种醋酸阿比特龙的合成方法及其中间体
CA3207282A1 (en) 2021-02-15 2022-08-18 Matthew J. Sharp Abiraterone prodrugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2742331B2 (ja) * 1992-03-31 1998-04-22 ブリテイツシユ・テクノロジー・グループ・リミテツド 癌治療に有用な１７位置換ステロイド
US5604213A (en) * 1992-03-31 1997-02-18 British Technology Group Limited 17-substituted steroids useful in cancer treatment
GB2282377B (en) 1993-09-30 1997-09-03 British Tech Group Synthesis of 17-(3-pyridyl) steroids
GB0418900D0 (en) * 2004-08-24 2004-09-29 Btg Int Ltd Novel salt forms

Also Published As

Publication number Publication date
NZ553085A (en) 2010-08-27
AU2005276298B2 (en) 2011-06-23
PL1789432T3 (pl) 2010-11-30
BRPI0514543A (pt) 2008-06-17
JP5069561B2 (ja) 2012-11-07
CN102863498B (zh) 2015-04-08
EP1789432A1 (en) 2007-05-30
ES2345345T3 (es) 2010-09-21
CN101044155A (zh) 2007-09-26
US20130090468A1 (en) 2013-04-11
CN102863498A (zh) 2013-01-09
US20070249836A1 (en) 2007-10-25
SI1789432T1 (sl) 2010-10-29
AU2005276298A1 (en) 2006-03-02
DK1789432T3 (da) 2010-08-16
US7700766B2 (en) 2010-04-20
ATE472553T1 (de) 2010-07-15
CA2576922A1 (en) 2006-03-02
CA2576922C (en) 2013-05-07
KR20120135931A (ko) 2012-12-17
DE602005022083D1 (de) 2010-08-12
US8338588B2 (en) 2012-12-25
KR101245727B1 (ko) 2013-03-25
WO2006021776A1 (en) 2006-03-02
EP1789432B1 (en) 2010-06-30
MX2007002032A (es) 2007-10-11
US20120053340A1 (en) 2012-03-01
JP2008510780A (ja) 2008-04-10
PT1789432E (pt) 2010-08-09
KR101358661B1 (ko) 2014-02-07
US20150329585A1 (en) 2015-11-19
KR20070049171A (ko) 2007-05-10
US20100152437A1 (en) 2010-06-17
CN101044155B (zh) 2012-10-10
HK1180694A1 (zh) 2013-10-25
HK1103091A1 (en) 2007-12-14
CY1110800T1 (el) 2015-06-10
GB0418900D0 (en) 2004-09-29
US8076474B2 (en) 2011-12-13
AU2005276298C1 (en) 2012-02-02

Similar Documents

Publication Publication Date Title
HK1180694A1 (zh) 阿比特龍- -酯的甲磺酸鹽以及從甲基．叔丁基醚溶液中回收阿比特龍- -酯的甲磺酸鹽
ES2531190T3 (es) Método para producir un compuesto de 4-oxoquinolina
EA200500239A1 (ru) Новый способ синтеза (1s)-4-,5-диметокси-1-(метиламинометил)-бензоциклобутана и его солей присоединения и применение при синтезе ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
CR7691A (es) Nuevo procedimiento de sintesis de ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
DK2057126T3 (da) Fremgangsmåde til fremstilling af 3-dihalomethyl-pyrazol-4-carboxylsyrederivater
RS53379B (en) N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES AND THE PROCEDURE FOR THEIR PREPARATION
EP2123636A4 (en) PROCESS FOR THE PREPARATION OF AN AMINOACETYLPYRROLIDINECARBONITRILE DERIVATIVE
GEP20105033B (en) Therapeutic agent for diabetes
WO2009083940A3 (en) Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts
WO2009153461A3 (fr) Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro-2h-3- benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
EA200901563A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
UY29857A1 (es) Derivados de la 4-amino-quinazolina, su preparación y su aplicación en terapéutica.
NZ601805A (en) Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
TW200612959A (en) Method for preparing hydroxamic acids
DE602006014001D1 (de) Herstellung von 2-aminothiazol-5-carbonsäurederivaten
WO2008068423A3 (fr) Derives de pyrrole, leur preparation et leur utilisation en therapeutique.
DE602007002486D1 (de) Verfahren zur herstellung von 1-halogen-2,7-naphthyridinylderivaten
JO3189B1 (ar) طريقة جديدة لتخليق (e2) -3- (3, 4- داي ميثوكسي فينيل)بروب-2 - يننيتريل واستخدامها لتخليق ايفابرادين والاملاح المضافة منها مع حمض مقبول صيدلانيا
HK1120788A1 (zh)
MY146275A (en) 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives
CY1106126T1 (el) Μεθοδος δια την παρασκευην ενωσεων 2-(4-αλκυλο-1-πιπepαζινυλο)-βενζαλδεϋδης και-βενζυλιδενυλιου δια νουκλεοφιλικης αρωματικης υποκαταστασεως 2-φθοροβενζαλδεϋδης δια 4-αλκυλο-1-πιπepαζινης, εις υδωρ ως διαλυτην
NO20064422L (no) Krystallinske former av 5,11-dihydro-11-etyl-5-metyl-8{2-{(1-oksido-4-kinolin 1)oksy}etyl}-6H-dipyrido[3,2-B:2',3'-E][1,4]diazepin--on
WO2011023280A8 (en) Process for making 1-hydroxyalkylidene-1,1-biphosphonic acids
WO2007025696A3 (en) Process for making substituted piperazinyl compounds
TW200738605A (en) Process for the production of (alkoxycarbonylamino)alkyl sulfonates